Navigation Links
Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
Date:3/9/2009

Conference Call and Webcast Information

Interleukin Genetics, Inc. will host a live conference call and webcast today at 4:30 p.m. EDT. To access the live call, dial 877-795-3646 (domestic) or 719-325-4833 (international). The live webcast will be available at the Investors section of the Company's website, www.ilgenetics.com.

The webcast will be archived following the call at www.ilgenetics.com.

About Interleukin Genetics

Interleukin Genetics, Inc. (NYSE: Alternext US: ILI), is a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market. Focused on the future of health and medicine, Interleukin Genetics uses its leading genetics research and scientific capabilities to develop and test innovative preventive and therapeutic products. Interleukin Genetics is headquartered in Waltham, MA. For more information about Interleukin Genetics, its products and ongoing programs, please visit http://www.ilgenetics.com.

Certain statements contained herein are "forward-looking" statements including statements regarding our ability to develop diagnostic, personalized nutritional and therapeutic products to prevent or treat diseases of inflammation and other genetic variations, our ability to screen nutritional compounds for their effects on inflammatory responses and other genetic variations, given specific genetic patterns and our ability to make progress in advancing our core technologies. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
6. Interleukin Genetics Retains Top Life Science Communications Firms
7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Village, Calif. (PRWEB) January 15, 2014 ... treatment and management through the genomic analysis of tumor ... offer Therapy Finder™, a web-based cancer decision support application ... reporting option with Cynvenio’s ClearID™ genomic test, Therapy Finder ...
(Date:1/15/2014)... This webinar will focus on EMA and FDA ... biosimilars. , Regulatory frameworks are evolving many countries to ... complex nature of biopharmaceuticals makes the demonstration of biosimilarity ... Based on the specific aspects of biosimilar drug development ...
(Date:1/15/2014)... VA (PRWEB) January 15, 2014 Two ... have continued their sponsorship of an annual competition for ... in, and access to, innovative STEM study. The competition ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
(Date:1/15/2014)... 2013 was a banner year of continued innovation ... continued independent research led by the team at Wake ... million grant from the Susanne Marcus Collins Foundation, had ... reviewed journal, Amy Grant highlighted Brainwave Optimization® in First ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... Advanced BioHealing, Inc. (ABH), a leader in commercializing ... medicine , today announced that Kevin Rakin , Chairman ... 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, ... take place at the Westin St. Francis Hotel in San ...
... DIEGO, Jan. 4, 2011 Gen-Probe Incorporated (Nasdaq: ... the 29th Annual J.P. Morgan Healthcare Conference in San Francisco ...  The presentation is scheduled to be webcast live and may ... Gen-Probe,s website at www.gen-probe.com . The webcast will be ...
... NEW YORK, Jan. 4, 2011 Rx Communications Group, ... preparing biotechnology executives for media interviews with financial as ... at Biotech Showcase™ 2011 taking place in San Francisco ... 9:00 am, PT. The discussion will focus on media ...
Cached Biology Technology:Advanced BioHealing to Present at 29th Annual J.P. Morgan Healthcare Conference 2Gen-Probe to Webcast Presentation at the 29th Annual J.P. Morgan Healthcare Conference 2Rx Communications Group to Host Panel Discussion for Biotechnology Executives on Communicating with the Media 2Rx Communications Group to Host Panel Discussion for Biotechnology Executives on Communicating with the Media 3
(Date:4/16/2014)... TALLAHASSEE, Fla. Florida State University researchers have identified ... deterioration of bone density and muscle mass with obesity. ... heavier you were the better your bones would be ... Ilich-Ernst, the Hazel Stiebeling Professor of Nutrition at Florida ...
(Date:4/16/2014)... Nicolas Doucet of the Centre INRSInstitut Armand-Frappier has just received ... in the amount of nearly US$600,000. The 5-year grant is ... called RNases and to explore their biomedical potential in the ... , "Receiving a grant at this level is ...
(Date:4/16/2014)... densely packed array of finger-like projections called microvilli ... intestines., Vanderbilt University researchers have now discovered how intestinal ... absorbing nutrients and defending against pathogens. The findings, published ... a role for adhesion molecules in brush border assembly ...
Breaking Biology News(10 mins):Researchers: Obesity can amplify bone and muscle loss 2High-level NIH grant goes to professor Nicolas Doucet of INRS 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 2Vanderbilt researchers discover how intestinal cells build nutrient-absorbing surface 3
... repair proteins enables bacteria to prioritise the repair of the ... the instructions necessary for living cells to function. The ... and published in Molecular Cell (Dec. 2010), reveals ... of bacteria and humans than had been suspected. ...
... Biosensors, Logic, and Nano-Biofuel Cells," will be the focus ... Nanotechnology Innovation Summit 10 http://www.nsti.org/events/NNI/ , at ... event celebrates the 10th anniversary of the national nanotechnology ... in New Jersey selected for this exposition featuring practical ...
... World-leading scientists, ethicists, policymakers, and cancer patient advocates will ... Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. ... discuss the latest developments in a radical new approach ... aimed at protecting healthy individuals from the disease. ...
Cached Biology News:New research reveals details of microbe's extraordinary maintenance and repair system 2Directed self-assembly of vertical nanotubes for biosensors, logic, nano-biofuel cells 2Experts converge at Arizona State University for first preventive cancer vaccine conference 2
Human alpha-1-antitrypsin. No cross-reactivity with alpha-1-acid glycoprotein, serum albumin or other serum proteins....
Recombinant Mouse LIGHT/TNFSF14...
Request Info...
... strains are high-performance BL21 ... protein yield in T7 ... 1). Because the T7 ... more rapidly than E. ...
Biology Products: